361 related articles for article (PubMed ID: 26234760)
1. Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid.
Tran CD; Grice DM; Wade B; Kerr CA; Bauer DC; Li D; Hannan GN
Future Microbiol; 2015; 10(8):1339-53. PubMed ID: 26234760
[TBL] [Abstract][Full Text] [Related]
2. Early life events influence whole-of-life metabolic health via gut microflora and gut permeability.
Kerr CA; Grice DM; Tran CD; Bauer DC; Li D; Hendry P; Hannan GN
Crit Rev Microbiol; 2015; 41(3):326-40. PubMed ID: 24645635
[TBL] [Abstract][Full Text] [Related]
3. The role of the gut microbiota in NAFLD.
Leung C; Rivera L; Furness JB; Angus PW
Nat Rev Gastroenterol Hepatol; 2016 Jul; 13(7):412-25. PubMed ID: 27273168
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
[TBL] [Abstract][Full Text] [Related]
5. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
6. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
8. The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy Management.
Flowers SA; Ellingrod VL
Pharmacotherapy; 2015 Oct; 35(10):910-6. PubMed ID: 26497477
[TBL] [Abstract][Full Text] [Related]
9. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
[TBL] [Abstract][Full Text] [Related]
10. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
Brandl K; Schnabl B
Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
[TBL] [Abstract][Full Text] [Related]
11. The gut-liver axis.
Visschers RG; Luyer MD; Schaap FG; Olde Damink SW; Soeters PB
Curr Opin Clin Nutr Metab Care; 2013 Sep; 16(5):576-81. PubMed ID: 23873346
[TBL] [Abstract][Full Text] [Related]
12. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
Stärkel P; Leclercq S; de Timary P; Schnabl B
Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
[TBL] [Abstract][Full Text] [Related]
13. Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting.
Genton L; Cani PD; Schrenzel J
Clin Nutr; 2015 Jun; 34(3):341-9. PubMed ID: 25459400
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
Frazier TH; DiBaise JK; McClain CJ
JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
[TBL] [Abstract][Full Text] [Related]
15. Influence of the human intestinal microbiome on obesity and metabolic dysfunction.
Tilg H; Adolph TE
Curr Opin Pediatr; 2015 Aug; 27(4):496-501. PubMed ID: 26087428
[TBL] [Abstract][Full Text] [Related]
16. Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health.
Joyce SA; Gahan CG
Annu Rev Food Sci Technol; 2016; 7():313-33. PubMed ID: 26772409
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota.
Guarino MP; Cicala M; Putignani L; Severi C
World J Gastroenterol; 2016 Dec; 22(45):9871-9879. PubMed ID: 28018095
[TBL] [Abstract][Full Text] [Related]
18. The Gut-Liver Axis in the Control of Energy Metabolism and Food Intake in Animals.
Ringseis R; Gessner DK; Eder K
Annu Rev Anim Biosci; 2020 Feb; 8():295-319. PubMed ID: 31689373
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and its pathophysiology in disease paradigms.
Festi D; Schiumerini R; Birtolo C; Marzi L; Montrone L; Scaioli E; Di Biase AR; Colecchia A
Dig Dis; 2011; 29(6):518-24. PubMed ID: 22179206
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.
Cani PD; Plovier H; Van Hul M; Geurts L; Delzenne NM; Druart C; Everard A
Nat Rev Endocrinol; 2016 Mar; 12(3):133-43. PubMed ID: 26678807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
